Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01058083 · ClinicalTrials.gov registry record · Phase 2

Safety Study of BMS-770767 in Subjects With Hypercholesterolemia

A Phase 2 study of Dyslipidemia, sponsored by Bristol-Myers Squibb.

Completed
Registry status
Phase 2
Development phase
81
Enrollment target
14
Study locations

NCT01058083 is a Phase 2 study of Dyslipidemia that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 81 participants, below the 361-participant average among 40 other Dyslipidemia trials with a reported enrollment target (78% lower). The trial reports 14 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01058083, a Phase 2 study of Dyslipidemia, has completed, sponsored by Bristol-Myers Squibb.

COMPLETED
Registry status
Phase 2
Development phase
81 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)

Conditions Studied

Dyslipidemia

Interventions

  • DRUG Placebo
  • DRUG BMS-770767

Study Locations (14)

New South Wales

  • Local Institution - Blacktown
  • Local Institution - Hornsby

Queensland

  • Local Institution - Caboolture
  • Local Institution - South Brisbane

Ontario

  • Local Institution - Brampton
  • Local Institution - Toronto

Quebec

  • Local Institution - Mirabel
  • Local Institution - Montreal

Arkansas

  • Harrell, Robert - Little Rock

Texas

  • Cetero Research - San Antonio - San Antonio

South Australia

  • Local Institution - Daw Park

Western Australia

  • Local Institution - Nedlands

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2010-05
Est. Completion 2011-03
Phase Phase 2

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01058083

The ClinicalTrials.gov registry entry for NCT01058083 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 361-participant average among 40 other Dyslipidemia trials with a reported enrollment target (78% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dyslipidemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01058083 reports 14 study locations spanning 10 distinct geographic areas - top geographies include New South Wales, Queensland, Ontario.

Frequently Asked Questions

What is clinical trial NCT01058083 about?

NCT01058083 is a clinical study titled "Safety Study of BMS-770767 in Subjects With Hypercholesterolemia". The purpose of this study is to assess the safety, tolerability and pharmacodynamic effects on LDL cholesterol (LDL-C)

What is the current status of trial NCT01058083?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2010-05. Estimated completion is 2011-03.

What conditions does trial NCT01058083 study?

This clinical trial studies the following conditions: Dyslipidemia.

What interventions are being tested in trial NCT01058083?

The interventions under investigation include: Placebo (DRUG), BMS-770767 (DRUG).

Who is sponsoring clinical trial NCT01058083?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01058083 being conducted?

This trial has 14 study locations across Arkansas, Texas, New South Wales, Queensland, South Australia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dyslipidemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dyslipidemia

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.